← Open Payments lookup

PHILIP MCKAY: Open Payments

NPI 1437485281 · VENTURA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$490 in 16 payments from 8 companies in 2025. Trend: 2023 $750 · 2024 $870 · 2025 $490

Food & beverage: $490
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$258
Gilead Sciences, Inc.3$84
Aurinia Pharma U.S., Inc.1$29
Phathom Pharmaceuticals, Inc.1$29
Ardelyx, Inc.1$28
Dexcom, Inc.1$27
ABBVIE INC.1$18
Lilly USA, LLC1$16

Products named: FARXIGA, LOKELMA, LUPKYNIS, VOQUEZNA, IBSRELA, Dexcom G6 Transmitter, RINVOQ, MOUNJARO.

Industry payments across CA — which companies pay providers there.